You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CEACAM5

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

Colorectal Cancer Trial in Japan, Spain, United States (M9140)

Recruiting
  • Colorectal Cancer
  • Houston, Texas
  • +4 more
Jul 15, 2022

Non-squamous NSCLC Trial in Worldwide (Tusamitamab ravtansine)

Recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Tusamitamab ravtansine
  • Edegem, Belgium
  • +18 more
Aug 3, 2022

Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
  • +15 more
Jan 13, 2023

Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

Active, not recruiting
  • Colorectal Cancer
  • Los Angeles, California
  • +12 more
Aug 19, 2022

Metastatic Colorectal Cancer Trial in Washington (TF2/IMP288)

Withdrawn
  • Metastatic Colorectal Cancer
  • Washington, District of Columbia
    Georgetown University Medical Center
Aug 12, 2021

Adenocarcinoma Gastric, Gastrooesophageal Cancer Trial in Worldwide (Ramucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701))

Recruiting
  • Adenocarcinoma Gastric
  • Gastrooesophageal Cancer
  • Ramucirumab (CYRAMZA®)
  • Tusamitamab ravtansine (SAR408701)
  • Bruxelles, Belgium
  • +22 more
Jan 16, 2023

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) Trial in Worldwide (SAR408701 (Tusamitamab ravtansine), Pembrolizumab,

Recruiting
  • Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
  • SAR408701 (Tusamitamab ravtansine)
  • +4 more
  • Westwood, Kansas
  • +26 more
Aug 11, 2022

Tumor Malignant Trial in Kashiwa-Shi, Nagoya-Shi, Sunto-Gun (SAR408701, dexamethasone, naphazoline)

Completed
  • Neoplasm Malignant
  • Kashiwa-Shi, Japan
  • +2 more
Jan 6, 2023

Advanced Solid Tumours Trial (EBC-129, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumours
  • (no location specified)
Jan 18, 2023

Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in United States (IMMU-130)

Withdrawn
  • Metastatic Colorectal Cancer
  • +2 more
  • Santa Monica, California
  • +6 more
Aug 12, 2021

Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate

Recruiting
  • Metastatic Breast Cancer
  • sacituzumab govitecan (IMMU-132)
  • +4 more
  • Beijing, China
  • +43 more
Apr 19, 2022

Sepsis, Molecular Diagnosis Trial in Tarragona (Septicyte Rapid ®, FilmArray® blood culture identification (BCID2®))

Recruiting
  • Sepsis
  • Molecular Diagnosis
  • Septicyte Rapid ®
  • FilmArray® blood culture identification (BCID2®)
  • Tarragona, Spain
    Alejandro Rodriguez
Apr 17, 2023